Twins born from 13-year-old frozen sperm

NewsGuard 100/100 Score

Reports from Taiwan say the sperm taken from a man with testicular cancer 13 years ago has been successfully used to impregnate his wife.

The man was diagnosed with testicular cancer when he was 23, and sperm was taken and frozen before chemotherapy was used to treat the cancer as it was expected to render him infertile.

The 13-year-old frozen sperm of the former testicular cancer patient was used to artificially inseminate his wife who gave birth to healthy twin boys.

Chen, now age 36, has completely recovered from the cancer and is in good health and his wife became pregnant with two of the four banked embryos following a 37-week pregnancy.

Testicular cancer is an abnormal, rapid, and invasive cancer of the testicles and is one of the most common forms of cancer in young men 15 to 40 years old, accounting for 1% of all cancers in men.

Between 6,000 and 8,000 men are diagnosed with testicular cancers each year and treatment can involve surgery, radiotherapy and chemotherapy and in most cases fertility is compromised.

As testicular cancer strikes men at an age when most want to father children, nerve-sparing surgery and sperm banking is recommended by most doctors.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
IVF add-on may be expensive, invasive, and ineffective, study finds